INHIBITION BY PERHEXILINE OF OXIDATIVE-PHOSPHORYLATION AND THE BETA-OXIDATION OF FATTY-ACIDS - POSSIBLE ROLE IN PSEUDOALCOHOLIC LIVER-LESIONS
INHIBITION BY PERHEXILINE OF OXIDATIVE-PHOSPHORYLATION AND THE BETA-OXIDATION OF FATTY-ACIDS - POSSIBLE ROLE IN PSEUDOALCOHOLIC LIVER-LESIONS
复制标题
DOI:
10.1016/0270-9139(94)90296-8
复制
发表时间:
1994-04-01
期刊:
影响因子:
13.5
通讯作者:
PESSAYRE, D
中科院分区:
文献类型:
--
作者:
DESCHAMPS, D;DEBECO, V;PESSAYRE, D
In an attempt to better understand the mechanisms for pseudoalcoholic liver lesions in human beings, we determined the effects of perhexiline on mitochondrial functions in mice and rats. A first series of studies suggested that protonated perhexiline entered mouse mitochondria along the mitochondrial membrane potential. Release of a proton in the mitochondrial matrix led to uncoupling of oxidative phosphorylation, and accumulation of perhexiline inhibited complexes I and II of the respiratory chain, decreased ATP formation in vitro and decreased the mitochondrial beta-oxidation of long-, medium- and short-chain fatty acids in vitro and in vivo in mice. In cultured rat hepatocytes, exposure for 24 hr to 25 mumol/L perhexiline markedly decreased hepatocellular ATP and cell viability. Exposure to 5 mumol/L perhexiline did not modify ATP and viability but decreased the beta-oxidation of palmitic acid uniformly labeled with carbon 14 by 38%, increased hepatocyte triglyceride levels by 98% and produced microvesicular steatosis after 72 hr of culture. We conclude that perhexiline is concentrated inside mitochondria, where it inhibits both oxidative phosphorylation and the mitochondrial beta-oxidation of fatty acids. These effects may contribute to the development of necrosis, steatosis and possibly certain other pseudoalcoholic liver lesions in human beings.